These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 27150250

  • 1. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
    Moradin N, Torre S, Gauthier S, Tam M, Hawari J, Vandercruyssen K, De Spiegeleer B, Fortin A, Stevenson MM, Gros P.
    Malar J; 2016 May 06; 15(1):260. PubMed ID: 27150250
    [Abstract] [Full Text] [Related]

  • 2. Cysteamine, the molecule used to treat cystinosis, potentiates the antimalarial efficacy of artemisinin.
    Min-Oo G, Fortin A, Poulin JF, Gros P.
    Antimicrob Agents Chemother; 2010 Aug 06; 54(8):3262-70. PubMed ID: 20479197
    [Abstract] [Full Text] [Related]

  • 3. Genetic analysis in mice identifies cysteamine as a novel partner for artemisinin in the treatment of malaria.
    Min-Oo G, Gros P.
    Mamm Genome; 2011 Aug 06; 22(7-8):486-94. PubMed ID: 21437649
    [Abstract] [Full Text] [Related]

  • 4. Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.
    Guiguemde WA, Hunt NH, Guo J, Marciano A, Haynes RK, Clark J, Guy RK, Golenser J.
    Antimicrob Agents Chemother; 2014 Aug 06; 58(8):4745-54. PubMed ID: 24913162
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin.
    Bayih AG, Folefoc A, Mohon AN, Eagon S, Anderson M, Pillai DR.
    Malar J; 2016 Dec 01; 15(1):579. PubMed ID: 27903279
    [Abstract] [Full Text] [Related]

  • 6. Oral artesunate prevents Plasmodium berghei Anka infection in mice.
    Gumede B, Folb P, Ryffel B.
    Parasitol Int; 2003 Mar 01; 52(1):53-9. PubMed ID: 12543147
    [Abstract] [Full Text] [Related]

  • 7. Controlled release of artemisone for the treatment of experimental cerebral malaria.
    Golenser J, Buchholz V, Bagheri A, Nasereddin A, Dzikowski R, Guo J, Hunt NH, Eyal S, Vakruk N, Greiner A.
    Parasit Vectors; 2017 Mar 01; 10(1):117. PubMed ID: 28249591
    [Abstract] [Full Text] [Related]

  • 8. Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium.
    Min-Oo G, Ayi K, Bongfen SE, Tam M, Radovanovic I, Gauthier S, Santiago H, Rothfuchs AG, Roffê E, Sher A, Mullick A, Fortin A, Stevenson MM, Kain KC, Gros P.
    Exp Parasitol; 2010 Aug 01; 125(4):315-24. PubMed ID: 20219464
    [Abstract] [Full Text] [Related]

  • 9. Artesunate-erythropoietin combination for murine cerebral malaria treatment.
    Bienvenu AL, Ferrandiz J, Kaiser K, Latour C, Picot S.
    Acta Trop; 2008 May 01; 106(2):104-8. PubMed ID: 18359468
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.
    Odhiambo OC, Wamakima HN, Magoma GN, Kirira PG, Malala BJ, Kimani FT, Muregi FW.
    Malar J; 2017 Jul 03; 16(1):268. PubMed ID: 28673299
    [Abstract] [Full Text] [Related]

  • 11. The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate.
    Peters W, Stewart LB, Robinson BL.
    Ann Trop Med Parasitol; 2005 Jul 03; 99(5):457-72. PubMed ID: 16004705
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of intranasal administration of artesunate in experimental cerebral malaria.
    Marijon A, Bonnot G, Fourier A, Bringer C, Lavoignat A, Gagnieu MC, Bienvenu AL, Picot S.
    Malar J; 2014 Dec 16; 13():501. PubMed ID: 25516091
    [Abstract] [Full Text] [Related]

  • 13. Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo.
    Khoury DS, Cromer D, Elliott T, Soon MSF, Thomas BS, James KR, Best SE, Aogo RA, Engel JA, Gartlan KH, Akter J, Sebina I, Haque A, Davenport MP.
    Int J Parasitol; 2017 Dec 16; 47(14):913-922. PubMed ID: 28864033
    [Abstract] [Full Text] [Related]

  • 14. In vivo validation of anti-malarial activity of crude extracts of Terminalia macroptera, a Malian medicinal plant.
    Haidara M, Haddad M, Denou A, Marti G, Bourgeade-Delmas S, Sanogo R, Bourdy G, Aubouy A.
    Malar J; 2018 Feb 05; 17(1):68. PubMed ID: 29402267
    [Abstract] [Full Text] [Related]

  • 15. Synergistic anti-malarial action of cryptolepine and artemisinins.
    Forkuo AD, Ansah C, Boadu KM, Boampong JN, Ameyaw EO, Gyan BA, Arku AT, Ofori MF.
    Malar J; 2016 Feb 16; 15():89. PubMed ID: 26879905
    [Abstract] [Full Text] [Related]

  • 16. Interaction between rifampicin, amodiaquine and artemether in mice infected with chloroquine resistant Plasmodium berghei.
    Badejo JA, Abiodun OO, Akinola O, Happi CT, Sowunmi A, Gbotosho GO.
    Malar J; 2014 Aug 05; 13():299. PubMed ID: 25091936
    [Abstract] [Full Text] [Related]

  • 17. Slow and continuous delivery of a low dose of nimodipine improves survival and electrocardiogram parameters in rescue therapy of mice with experimental cerebral malaria.
    Martins YC, Clemmer L, Orjuela-Sánchez P, Zanini GM, Ong PK, Frangos JA, Carvalho LJ.
    Malar J; 2013 Apr 24; 12():138. PubMed ID: 23617605
    [Abstract] [Full Text] [Related]

  • 18. Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.
    Guo J, Guiguemde AW, Bentura-Marciano A, Clark J, Haynes RK, Chan WC, Wong HN, Hunt NH, Guy RK, Golenser J.
    Antimicrob Agents Chemother; 2012 Jan 24; 56(1):163-73. PubMed ID: 22006004
    [Abstract] [Full Text] [Related]

  • 19. Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum.
    Duffey M, Sanchez CP, Lanzer M.
    Malar J; 2018 Mar 20; 17(1):121. PubMed ID: 29558913
    [Abstract] [Full Text] [Related]

  • 20. The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.
    Dai M, Freeman B, Bruno FP, Shikani HJ, Tanowitz HB, Weiss LM, Reznik SE, Stephani RA, Desruisseaux MS.
    Life Sci; 2012 Oct 15; 91(13-14):687-92. PubMed ID: 22820174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.